The CEO of a plan that messed up the production of 15 million Johnson & Johnson doses of coronavirus vaccines will receive 51 percent compensation by 2020, according to a report by The Washington Post.
Robert Kramer, CEO of Emergent Biosolutions, received $ 5.6 million in 2020, according to a public filing reviewed by the Post on Friday.
The company president received a salary of $ 893,000, $ 1.4 million from stock options, $ 2.1 million from stock awards and a $ 1.2 million bonus, the Post said.
According to the filing, the company increased Kramer’s wages after the company’s production expanded and the CEO responded to the pandemic.
The company also reported a 41 percent increase in sales in 2020. Kramer rose to CEO of the company in 2019 and has been with the company since 2012, according to the newspaper.
Emergent saw that increase last year mainly as a result of a federal contract that raised the company $ 628 million to help combat the coronavirus pandemic, the paper said.
However, The Post noted that the bonuses before the The company’s Maryland plant has contaminated 15 million Johnson & Johnson vaccine doses.
In late March, problems surrounding vaccine production at the Emergent plant became public after the Johnson & Johnson vaccine was contaminated with ingredients from the AstraZeneca vaccine, the Post said.
AstraZeneca’s materials have been completely removed from the plant and Johnson & Johnson will take charge of overseeing the plant.
The White House warned on Friday that states will receive a significantly lower amount of the Johnson & Johnson vaccine in the coming weeks as a result of the accident.
The New York Times reported earlier this week that there was a high risk of cross-contamination found it audits of the facility last year. The staff would also be under-skilled.
The Hill has contacted Emergent Solutions for comment.